<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Combination chemotherapy with CHOP (<z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, Adriamycin, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="8382">prednisone</z:chebi>) and HOP (Adrimycin, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="8382">prednisone</z:chebi>, was used as treatment for patients with pathologically staged, advanced non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Among 204 evaluable patients treated on CHOP there were 71% complete remissions with 92% overall responses </plain></SENT>
<SENT sid="2" pm="."><plain>Among the 216 evaluable patients on HOP there were 61% complete remissions and 88% responses </plain></SENT>
<SENT sid="3" pm="."><plain>Complete remission rates among patients with histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were comparable to those of patients with lymphocytic disease </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with nodular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> had higher rates of complete remission than their counterparts with diffuse <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>This was noted with both CHOP (78% vs. 67%) and HOP (67% vs. 60%) induction therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Rapid responses were common, as more than 14% of complete remissions and 66% of overall responses were achieved with the first course of treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Patients in complete remission have been maintained with either <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="8382">prednisone</z:chebi> (COP) or arabinosyl <z:chebi fb="1" ids="16040">cytosine</z:chebi>, <z:chebi fb="0" ids="28445">vincristine</z:chebi>, and <z:chebi fb="0" ids="8382">prednisone</z:chebi> (OAP) </plain></SENT>
<SENT sid="8" pm="."><plain>After 1 year, 86% of patients on COP and 80% on OAP are projected to be free of disease </plain></SENT>
</text></document>